Recent Finacing
Recent Raise
ReAlta Life Sciences is a clinical-stage biopharmaceutical company developing pegtarazimod, a peptide that targets both neutrophil- and complement-mediated inflammation.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at ReAlta Life Sciences.